10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001213900-21-041369`
Period End Date	20210630
Filing Date	20210810
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	f10q0621_relmada_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 44 Cash Flow Statement 54 Stockholders Equity 32

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`Cash`	$2.50M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`Cash`	$4.67M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$114.60M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$104.40M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	$79.46K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	$82.84K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$903.19K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.55M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$110.70M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$118.07M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	16.33M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$1.26K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	17.47M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	16.33M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	17.47M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Lease payments receivable long term	`LeasePaymentsReceivableLongTerm`	$86.38K	USD	Point-in-time
Lease payments receivable long term	`LeasePaymentsReceivableLongTerm`	$44.09K	USD	Point-in-time
Total assets	`Assets`	$118.19M	USD	Point-in-time
Total assets	`Assets`	$110.77M	USD	Point-in-time
Commitments and Contingencies (See Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (See Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.35M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.46M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.26M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.92M	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 17,468,819 and 16,332,939 shares issued and outstanding, respectively	`CommonStockValue`	$16.33K	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 17,468,819 and 16,332,939 shares issued and outstanding, respectively	`CommonStockValue`	$17.47K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$284.88M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$324.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-179.32M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-228.08M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$91.15M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$105.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$96.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$132.23M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$115.68M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$113.16M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$118.19M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$110.77M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$17.33M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$31.35M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$9.83M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.32M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$9.13M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.43M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$12.90M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$17.51M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$22.73M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$48.87M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$12.76M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$26.46M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-26.46M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-12.76M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-22.73M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-48.87M	USD	2 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$811.66K	USD	2 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$404.00K	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$742.78K	USD	2 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$322.81K	USD	1 Quarter
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	$12.81K	USD	1 Quarter
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	$-123.59K	USD	1 Quarter
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	$-176.38K	USD	2 Qtrs
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	$-158.80K	USD	2 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$1.22M	USD	1 Quarter
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-466.44K	USD	2 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$287.03K	USD	2 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-289.28K	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$1.64M	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$99.96K	USD	2 Qtrs
Total other (expenses) income	`NonoperatingIncomeExpense`	$-90.06K	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$939.88K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-48.77M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-26.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.79M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.56	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.45	USD	2 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-2.90	USD	2 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.73	USD	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	16.81M	shares	2 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	17.05M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.03M	shares	2 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.32M	shares	1 Quarter

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-48.77M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-26.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.79M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.26K	USD	2 Qtrs
Depreciation expense	`Depreciation`	$2.08K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$14.12M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$12.34M	USD	2 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$12.81K	USD	1 Quarter
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-123.59K	USD	1 Quarter
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-176.38K	USD	2 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-158.80K	USD	2 Qtrs
Unrealized loss (gain) on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$-466.44K	USD	2 Qtrs
Unrealized loss (gain) on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$287.03K	USD	2 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-38.90K	USD	2 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-35.78K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-183.33K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$645.69K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.11M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$442.51K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$536.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-796.16K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-33.30M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.38M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$62.36M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$56.87M	USD	2 Qtrs
Sale of short-term investments	`GainLossOnSaleOfInvestments`	$-22.39M	USD	2 Qtrs
Sale of short-term investments	`GainLossOnSaleOfInvestments`	$-66.43M	USD	2 Qtrs
Net cash provided by (used) in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-39.97M	USD	2 Qtrs
Net cash provided by (used) in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.55M	USD	2 Qtrs
Principal payments of notes payable	`RepaymentsOfNotesPayable`	$110.25K	USD	2 Qtrs
Principal payments of notes payable	`RepaymentsOfNotesPayable`	-	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$23.46M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$19.86M	USD	2 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$530.64K	USD	2 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$517.27K	USD	2 Qtrs
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	$5.62M	USD	2 Qtrs
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	$1.94M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$25.89M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$25.92M	USD	2 Qtrs
Net increase/(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-22.45M	USD	2 Qtrs
Net increase/(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$2.17M	USD	2 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.67M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$13.82M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.67M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$13.82M	USD	Point-in-time
Interest	`InterestPaidNet`	-	USD	2 Qtrs
Interest	`InterestPaidNet`	$954.00	USD	2 Qtrs
Cashless exercise of warrants for common stock	`CashlessEexerciseOfWarrants`	$36.00	USD	2 Qtrs
Cashless exercise of warrants for common stock	`CashlessEexerciseOfWarrants`	-	USD	2 Qtrs

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$91.15M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$96.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$132.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$113.16M	USD	Point-in-time
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$7.30M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$5.85M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$8.27M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$5.04M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$2.58M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$3.04M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$481.45K	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$1.46M	USD	1 Quarter
Cashless warrant exercise	`CashlessExerciseOfWarrantsValue`	-	USD	1 Quarter
Cashless warrant exercise	`CashlessExerciseOfWarrantsValue`	-	USD	1 Quarter
Options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$457.62K	USD	1 Quarter
Options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$73.02K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$467.77K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$49.50K	USD	1 Quarter
ATM offering, net of offering costs	`ATMOfferingNetOfOfferingCosts`	$23.46M	USD	1 Quarter
ATM offering, net of offering costs	`ATMOfferingNetOfOfferingCosts`	$19.86M	USD	1 Quarter
Net loss	`ProfitLoss`	$-22.22M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-26.55M	USD	1 Quarter
Net loss	`ProfitLoss`	$-10.67M	USD	1 Quarter
Balance	`StockholdersEquity`	$91.15M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$96.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$132.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$113.16M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.